Dr. Pazdur in at CDER, Leadership Developments in Key FDA Offices, and FDA Announces Reforms to Accelerate Biosimilars

Through our Venable FDA Pulse series, we provide insight into key developments within the Food and Drug Administration (FDA or the Agency), emerging trends, enforcement activity, and other topics impacting stakeholders….
By: Venable LLP